NIH-funded discoveries by UCSF's Kevan Shokat, PhD have produced the world’s first drugs that target mutations in the KRAS gene which cause a quarter of all cancerous tumors.
Our Global Cancer Program joined international collaborators at the African Organisation for Research and Training in Cancer (AORTIC) conference in Tunisia.
He was told cancer would kill him in two to four years. Fourteen years later, he credits a series of medications and treatments funded by the National Institutes of Health.
In September, our Office of Education and Training coordinated a Cancer Research Showcase for Graduate Students, designed to introduce the vibrant cancer research community at UCSF to students across PhD and MD/PhD programs who wish to pursue a degree in cancer biology.
Researchers from UC San Francisco, have discovered that a novel combination of immunotherapies can reprogram the immune environment of colon cancer tumors that spread to the liver.
Matching grant from Weill family creates collaborative research hub, uniting scientists from UCSF and Stanford Medicine to transform cancer care within a decade.